The effectiveness of colistin/levofloxacin compared to colistin/meropenem in the treatment of ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii: a randomized controlled clinical trial
Background and purpose: The treatment of ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii (CRAB) is still a great challenge. This study evaluated the effectiveness of the colistin/levofloxacin regimen compared to the usual colistin/meropenem regimen in the...
Main Authors: | Mahnaz Momenzadeh, Rasool Soltani, Fatemeh Shafiee, Atousa Hakamifard, Morteza Pourahmad, Saeed Abbasi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Research in Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2023;volume=18;issue=1;spage=39;epage=48;aulast=Momenzadeh |
Similar Items
-
Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021-07-01) -
The Efficacy of Colistin Combined with Amikacin or Levofloxacin against Pseudomonas aeruginosa Biofilm Infection
by: Yuhang Wang, et al.
Published: (2022-10-01) -
A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Critically Ill Patients: A Propensity Score-Matched Analysis
by: Wasan Katip, et al.
Published: (2020-09-01) -
Synergistic activity of fosfomycin–meropenem and fosfomycin–colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence
by: Yamuna Devi Bakthavatchalam, et al.
Published: (2020-04-01) -
EFFICACY OF COLISTIN AND CEFIDEROCOL ON CARBAPENEM RESISTANT Acinetobacter baumannii ISOLATES
by: Feyza Balci, et al.
Published: (2024-12-01)